1,039
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study

, , &
Article: 2231084 | Received 27 Mar 2023, Accepted 24 Jun 2023, Published online: 10 Jul 2023

References

  • Pépin M, Ferreira AC, Arici M, et al. Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment. Nephrol Dial Transplant. 2021;37(Suppl 2):1–8. doi: 10.1093/ndt/gfab262.
  • O’Lone E, Connors M, Masson P, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67(6):925–935. doi: 10.1053/j.ajkd.2015.12.028.
  • Olczyk P, Kusztal M, Gołębiowski T, et al. Cognitive impairment in end stage renal disease patients undergoing hemodialysis: markers and risk factors. IJERPH. 2022;19(4):2389. doi: 10.3390/ijerph19042389.
  • van Zwieten A, Wong G, Ruospo M, et al. Associations of cognitive function and education level with all-cause mortality in adults on hemodialysis: findings from the COGNITIVE-HD study. Am J Kidney Dis. 2019;74(4):452–462. doi: 10.1053/j.ajkd.2019.03.424.
  • Joseph SJ, Bhandari SS, Dutta S. Cognitive impairment and its correlates in chronic kidney disease patients undergoing haemodialysis. J Evol Med Dent Sci. 2019;8(36):2818–2822. doi: 10.14260/jemds/2019/611.
  • Guo Y, Tian R, Ye P, et al. Cognitive domain impairment and all-cause mortality in older patients undergoing hemodialysis. Front Endocrinol. 2022;13:828162. doi: 10.3389/fendo.2022.828162.
  • Griva K, Stygall J, Hankins M, et al. Cognitive impairment and 7-year mortality in dialysis patients. Am J Kidney Dis. 2010;56(4):693–703. doi: 10.1053/j.ajkd.2010.07.003.
  • Barbagallo M, Veronese N, Dominguez LJ. Magnesium in aging, health and diseases. Nutrients. 2021;13(2):463. doi: 10.3390/nu13020463.
  • Xiong J, He T, Wang M, et al. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. J Nephrol. 2019;32(5):791–802. doi: 10.1007/s40620-019-00601-6.
  • Leenders N, Vermeulen EA, van Ballegooijen AJ, et al. The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Clin Nutr. 2021;40(5):3133–3147. doi: 10.1016/j.clnu.2020.12.015.
  • Kirkland AE, Sarlo GL, Holton KF. The role of magnesium in neurological disorders. Nutrients. 2018;10(6):730. doi: 10.3390/nu10060730.
  • Al-Ghazali K, Eltayeb S, Musleh A, et al. Serum magnesium and cognitive function among qatari adults. Front Aging Neurosci. 2020;12:101. doi: 10.3389/fnagi.2020.00101.
  • Alam AB, Lutsey PL, Gottesman RF, et al. Low serum magnesium is associated with incident dementia in the ARIC-NCS cohort. Nutrients. 2020;12(10):3074. doi: 10.3390/nu12103074.
  • Balmuș IM, Strungaru SA, Ciobica A, et al. Preliminary data on the interaction between some biometals and oxidative stress status in mild cognitive impairment and Alzheimer’s disease patients. Oxid Med Cell Longev. 2017;2017:7156928. doi: 10.1155/2017/7156928.
  • Kieboom B, Licher S, Wolters FJ, et al. Serum magnesium is associated with the risk of dementia. Neurology. 2017;89(16):1716–1722. doi: 10.1212/WNL.0000000000004517.
  • Murray AM, Pederson SL, Tupper DE, et al. Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. Am J Kidney Dis. 2007;50(2):270–278. doi: 10.1053/j.ajkd.2007.05.010.
  • Dahbour SS, Wahbeh AM, Hamdan MZ. Mini mental status examination (MMSE) in stable chronic renal failure patients on hemodialysis: the effects of hemodialysis on the MMSE score. A prospective study. Hemodial Int. 2009;13(1):80–85. doi: 10.1111/j.1542-4758.2009.00343.x.
  • Harrell FE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Berlin: Springer. 2015.
  • Lu R, Xu C, Li Y, et al. The incidence prognosis and risk factors of cognitive impairment in maintenance haemodialysis patients. Blood Purif. 2019;47(1–3):101–108. doi: 10.1159/000493524.
  • Zhao Y, Song P, Zhang H, et al. Mediating effect of gait speed on the relationship between ankle-brachial index and mild cognitive impairment in hemodialysis patients. Semin Dial. 2023;36(2):162–169. doi: 10.1111/sdi.13089.
  • Tzeng NS, Chung CH, Lin FH, et al. Magnesium oxide use and reduced risk of dementia: a retrospective, nationwide cohort study in Taiwan. Curr Med Res Opin. 2018;34(1):163–169. doi: 10.1080/03007995.2017.1385449.
  • Tu X, Qiu H, Lin S, et al. Low levels of serum magnesium are associated with poststroke cognitive impairment in ischemic stroke patients. Neuropsychiatr Dis Treat. 2018;14:2947–2954. doi: 10.2147/NDT.S181948.
  • Lo K, Liu Q, Madsen T, et al. Relations of magnesium intake to cognitive impairment and dementia among participants in the women’s health initiative memory study: a prospective cohort study. BMJ Open. 2019;9(11):e030052. doi: 10.1136/bmjopen-2019-030052.
  • Thomassen JQ, Tolstrup JS, Nordestgaard BT, et al. Plasma concentrations of magnesium and risk of dementia: a general population study of 102648 individuals. Clin Chem. 2021;67(6):899–911. doi: 10.1093/clinchem/hvab041.
  • Li W, Jiao Y, Wang L, et al. Association of serum magnesium with insulin resistance and type 2 diabetes among adults in China. Nutrients. 2022;14(9):1799. doi: 10.3390/nu14091799.
  • Yue CY, Zhang CY, Huang ZL, et al. A novel U-shaped association between serum magnesium on admission and 28-day in-hospital all-cause mortality in the pediatric intensive care unit. Front Nutr. 2022;9:747035. doi: 10.3389/fnut.2022.747035.
  • Wang R, He M, Xu J. Initial serum magnesium level is associated with mortality risk in traumatic brain injury patients. Nutrients. 2022;14(19):4174. doi: 10.3390/nu14194174.
  • Panthofer AM, Lyu B, Astor BC, et al. Post-kidney transplant serum magnesium exhibits a U-shaped association with subsequent mortality: an observational cohort study. Transpl Int. 2021;34(10):1853–1861. doi: 10.1111/tri.13932.
  • Li Q, Chen Q, Zhang H, et al. Associations of serum magnesium levels and calcium-magnesium ratios with mortality in patients with coronary artery disease. Diabetes Metab. 2020;46(5):384–391. doi: 10.1016/j.diabet.2019.12.003.
  • Barbagallo M, Dominguez LJ. Magnesium and aging. Curr Pharm Des. 2010;16(7):832–839. doi: 10.2174/‑138161210790883679.
  • Toffa DH, Magnerou MA, Kassab A, et al. Can magnesium reduce Central neurodegeneration in Alzheimer’s disease? Basic evidences and research needs. Neurochem Int. 2019;126:195–202. doi: 10.1016/j.neuint.2019.03.014.
  • Yu X, Guan PP, Zhu D, et al. Magnesium ions inhibit the expression of tumor necrosis factor alpha and the activity of gamma-secretase in a beta-amyloid protein-dependent mechanism in APP/PS1 transgenic mice. Front Mol Neurosci. 2018;11:172. doi: 10.3389/fnmol.2018.00172.
  • Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clin Belg. 2019;74(1):41–47. doi: 10.1080/17843286.2018.1516173.
  • Mossello E. Hypertension, hypotension, longevity and dementia. Monaldi Arch Chest Dis. 2020;90(4). doi: 10.4081/monaldi.2020.1674.